Serina Therapeutics Inc (SER) support and resistance · rev $56.0K
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
This page maps Serina Therapeutics Inc (SER) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
SER currently screens at market cap $29.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SER 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SER quote page for the session range and the stock page for the full model.
Not investment advice.